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The random nature of transgene integration harbours
various pitfalls for development of production cell lines
including clonal variation in expression level and growth
characteristics. The CEMAX system is an expression
system for targeted integration of expression cassettes
via DNA double-strand break induced homologous
recombination. Stable high producers are available
within 4 weeks without the need of extensive clone
screening and process development.
Stable and high expression rates are ensured with the
CEMAX system due to targeted integration of a single
copy of the gene of interest at a transcriptionally highly
active site in the host cell genome. Producer cell lines
for various therapeutic product candidates were estab-
lished. These cell lines produced antibodies and highly
glycosylated antibody fusionp r o t e i n sa n ds h o w e dh i g h
clonal similarity. This made a platform fed-batch pro-
cess profitable.
The CEMAX expression system is based on a geneti-
cally modified CHO cell line bearing a tag at a highly
active genomic transcription site. The gene of interest
(GOI) is integrated via site-directed DNA double-strand
break-induced homologous recombination. The target
site comprises a screening and selection cassette, which
was used for initial development of the high producer
host cell. This exchangeable cassette is flanked by ele-
ments that facilitate site-directed integration by homolo-
gous recombination. These elements include regions of
homology for recombination with the CEMAX vector,
rudimentary selection markers that are activated during
recombination, and cleavage sites for the homing endo-
nuclease I-SceI (Meganuclease).
Transfection of the CEMAX vector comprising the
GOI along with transient Meganuclease activity triggers
a chain of events after cotransfection: DNA gets cleaved
by I-SceI and cellular DNA repair machinery is induced
by free DNA double-strand breaks. The CEMAX vector
comprising the GOI functions as a repair matrix using
recombination between homologous elements flanking
the DNA lesion. The GOI gets integrated and the rudi-
mentary selection markers become activated upon
homologous recombination. CEMAX producer cells
were selected at multi-well plate scale followed by analy-
sis for outgrowth of stable producer cells. The platform
process for fed-batch cultivation of various CEMAX
producer cells was applied after expansion to the scale
needed for production of protein material.
The idea of a platform process that is suitable for all
CEMAX producer cells was based on theoretical consid-
eration about similarity of cells due to site-directed inte-
gration and the observation that cell growth and
metabolism of CEMAX cell lines were comparable. This
was verified by the results of this study. Applying the
fed-batch process cell growth of CEMAX host cells and
CEMAX producer cells was comparable (Figure 1). The
development of the platform fed-batch process was
based on three small scale development steps: (1) basal
media screening, (2) feed medium optimization, and (3)
improvement of feeding regime. Process development in
1 L bioreactors is currently ongoing.
The fed-batch process comprises a chemically defined
and commercially available basal medium and the che-
mically defined feed solution CeloFeed (Celonic) supple-
mented according to the improved feeding regime. The
glucose level was maintained between 4.5 g/L and 7.5 g/
L. Glutamine was kept at a concentration above 0.8
mM. By applying the platform fed-batch process pro-
duct concentrations up to 690 mg/L were achieved with
CEMAX cell lines producing a glycosylated Fc fusion
protein after site-directed integration of the GOI (Figure
1). Achievable productivity for different protein products
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due to different requirements in protein processing and
secretion.
The platform fed-batch process was developed by
optimization based on commercial available and pro-
prietary basal and feed media formulations. It was suita-
ble for all producer cell lines derived of a particular
CEMAX host cell due to highly similar growth behavior
after site-directed integration of the gene of interest.
The platform process made product concentrations of
up to 0.7 g/L achievable. Animal derived component
free chemically defined medium and feed solution
ensure a robust and regulatory compliant process. By
combining the platform process with site-directed inte-
gration timelines in cell line development and process
development were shortened for faster entry in first-in-
man studies.
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Figure 1 Platform fed-batch process for CEMAX cell lines. Cells were cultivated in comparison to the CEMAX host cell line in shake flask scale.
The basal medium was a commercially available chemically defined medium and was used in combination with the proprietary chemically
defined feed solution CeloFeed. Product concentration was measured by Protein A HPLC.
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